About the Authors

Alienke J. Monsuur

Current address: Dutch Vaccine Institute, Bilthoven, The Netherlands

Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands

Paul I. W. de Bakker

Affiliations Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, United States of America, Division of Genetics, Brigham and Women's Hospital, Harvard-Partners Center for Genetics and Genomics, Boston, United States of America

Alexandra Zhernakova

Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands

Dalila Pinto

Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands

Willem Verduijn

Affiliation Section for Immunogenetics and Transplantation Immunology of the Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands

Jihane Romanos

Affiliation Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands

Renata Auricchio

Affiliation Department of Pediatrics and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II Naples, Napels, Italy

Ana Lopez

Affiliation Pediatric Gastroenterology Unit, Fundación Investigación Hospital La Fe, Valencia, Spain

David A. van Heel

Affiliation Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom

J. Bart A Crusius

Affiliation Department of Pathology, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands

Cisca Wijmenga

c.wijmenga@umcutrecht.nl

Affiliations Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands, Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands

Competing Interests

The HLA-DQ haplotyping was invented at the University Medical Centre Utrecht (UMC Utrecht) and will be developed and marketed by Genome Diagnostics BV. The UMC Utrecht may receive royalties from the worldwide sale of the technology. UMC Utrecht may distribute part of the royalty revenues to the inventors (CW and AM). None of the authors report a financial or other link with Genome Diagnostics BV. Genome Diagnostics had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.

Author Contributions

Conceived and designed the experiments: CW. Performed the experiments: AM AZ DP JR. Analyzed the data: AM AZ. Contributed reagents/materials/analysis tools: Pd WV Dv BC RA AL. Wrote the paper: Pd CW AM AZ.